Literature DB >> 36210409

Effect of Erythropoietin on Mononuclear Cells of the Bone Marrow and Spleen.

A P Lykov1,2, M A Surovtseva3, N A Bondarenko3, I I Kim3, Ya Sh Schwartz4, O V Poveshchenko.   

Abstract

We studied the effect of preconditioning of human bone marrow mononuclear cells with erythropoietin on the immunophenotype of immunocompetent cells and paracrine activity of mouse splenocytes. The expression of erythropoietin receptors on immunocompetent human bone marrow cells was shown to change after a short-term (60 min) exposure to erythropoietin. The number of T helpers carrying erythropoietin receptors decreased and the number of T suppressors, B lymphocytes, and monocytes carrying erythropoietin receptors increased. The presence of 30% conditioned medium from human bone marrow mononuclear cells or 33.4 U/ml of erythropoietin reduced apoptosis/necrosis, increased intracellular activity of NADPH-dependent oxidoreductases of splenocytes, and did not affect oxidative phosphorylation (did not enhance lactate production and glucose uptake by cells).
© 2022. Springer Science+Business Media, LLC, part of Springer Nature.

Entities:  

Keywords:  bone marrow mononuclear cells; erythropoietin; erythropoietin receptor; proliferation; splenocytes

Mesh:

Substances:

Year:  2022        PMID: 36210409     DOI: 10.1007/s10517-022-05602-3

Source DB:  PubMed          Journal:  Bull Exp Biol Med        ISSN: 0007-4888            Impact factor:   0.737


  6 in total

1.  Erythropoietin receptor is expressed on human peripheral blood T and B lymphocytes and monocytes and is modulated by recombinant human erythropoietin treatment.

Authors:  Katarzyna A Lisowska; Alicja Debska-Slizień; Ewa Bryl; Bolesław Rutkowski; Jacek M Witkowski
Journal:  Artif Organs       Date:  2010-05-31       Impact factor: 3.094

2.  Flow cytometric analysis of STAT5 phosphorylation and CD95 expression in CD4+ T lymphocytes treated with recombinant human erythropoietin.

Authors:  Katarzyna A Lisowska; Alicja Dębska-Ślizień; Aleksandra Jasiulewicz; Agnieszka Jóźwik; Bolesław Rutkowski; Ewa Bryl; Jacek M Witkowski
Journal:  J Recept Signal Transduct Res       Date:  2011-06       Impact factor: 2.092

Review 3.  Erythropoietin, a multifaceted protein with innate and adaptive immune modulatory activity.

Authors:  Chiara Cantarelli; Andrea Angeletti; Paolo Cravedi
Journal:  Am J Transplant       Date:  2019-04-25       Impact factor: 8.086

4.  Erythropoietin Receptor-Mediated Molecular Crosstalk Promotes T Cell Immunoregulation and Transplant Survival.

Authors:  Carolina Purroy; Robert L Fairchild; Toshiaki Tanaka; William M Baldwin; Joaquin Manrique; Joren C Madsen; Robert B Colvin; Alessandro Alessandrini; Bruce R Blazar; Miguel Fribourg; Chiara Donadei; Umberto Maggiore; Peter S Heeger; Paolo Cravedi
Journal:  J Am Soc Nephrol       Date:  2017-03-16       Impact factor: 10.121

Review 5.  Erythropoiesis, EPO, macrophages, and bone.

Authors:  Joshua T Eggold; Erinn B Rankin
Journal:  Bone       Date:  2018-03-15       Impact factor: 4.398

6.  Erythropoietin Directly Affects Human Macrophage Functionality.

Authors:  Olga V Melashchenko; Maxim E Meniailo; Vladimir V Malashchenko; Natalya D Gazatova; Andrei G Goncharov; Galina V Seledtsova; Victor I Seledtsov
Journal:  Curr Pharm Biotechnol       Date:  2018       Impact factor: 2.837

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.